References
- Bruijn LI, Miller TM, Cleveland DW. Unravelling the mechanisms involved in motor neuron degeneration in ALS. Annu Rev Neurosci. 2004;27:723–49.
- Cleveland DW, Rothstein JD. From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nat Rev Neurosci. 2001;2:806–19.
- Levy MM. Pathophysiology of oxygen delivery in respiratory failure. Chest. 2005;128:547–53.
- Wenger RH. Cellular adaptation to hypoxia: O2-sensing protein hydroxylases, hypoxia-inducible transcription factors, and O2-regulated gene expression. FASEB J. 2002;16:1151–62.
- Semenza GL. Involvement of oxygen-sensing pathways in physiologic and pathologic erythropoiesis. Blood. 2009;114: 2015–9.
- Brines M, Cerami A. Emerging biological roles for erythropoietin in the nervous system. Nat Rev Neurosci. 2005;6: 484–94.
- Butsch PO, Cudkowicz ME. Is erythropoietin a potential therapy for amyotrophic lateral sclerosis? Exp Neurol. 2007; 206:11–5.
- Siren AL, Fasshauer T, Bartels C, Ehrenreich H. Therapeutic potential of erythropoietin and its structural or functional variants in the nervous system. Neurotherapeutics. 2009;6: 108–27.
- Lauria G, Campanella A, Filippini G, Martini A, Penza P, Maggi L, . Erythropoietin in amyotrophic lateral sclerosis: a pilot, randomized, double-blind, placebo-controlled study of safety and tolerability. Amyotroph Lateral Scler. 2009;10:410–5.
- Brettschneider J, Widl K, Ehrenreich H, Riepe M, Tumani H. Erythropoietin in the cerebrospinal fluid in neurodegenerative diseases. Neurosci Lett. 2006;404:347–51.
- Brettschneider J, Widl K, Schattauer D, Ludolph AC, Tumani H. Cerebrospinal fluid erythropoietin (EPO) in amyotrophic lateral sclerosis. Neurosci Lett. 2007;416:257–60.
- Janik P, Kwiecinski H, Sokolowska B, Niebroj-Dobosz I. Erythropoietin concentration in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis. J Neural Transm. 2010;117:343–7.
- Just N, Moreau C, Lassalle P, Gosset P, Perez T, Brunaud-Danel V, . High erythropoietin and low vascular endothelial growth factor levels in cerebrospinal fluid from hypoxaemic ALS patients suggest an abnormal response to hypoxia. Neuromuscul Disord. 2007;17:169–73.
- Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293–9.
- Bremer M, Doerge RW. Statistics at the bench: a step-by-step handbook for biologists. New York: Cold Spring Harbor Laboratory Press; 2010.
- Moreau C, Gosset P, Brunaud-Danel V, Lassalle P, Degonne B, Destee A, . CSF profiles of angiogenic and inflammatory factors depend on the respiratory status of ALS patients. Amyotroph Lateral Scler. 2009;10:175–81.
- Embury SH, Garcia JF, Mohandas N, Pennathur-Das R, Clark MR. Effects of oxygen inhalation on endogenous erythropoietin kinetics, erythropoiesis, and properties of blood cells in sickle-cell anaemia. N Engl J Med. 1984;311:291–5.
- Chikuma M, Masuda S, Kobayashi T, Nagao M, Sasaki R. Tissue-specific regulation of erythropoietin production in the murine kidney, brain, and uterus. Am J Physiol Endocrinol Metab. 2000;279:1242–8.
- Horiguchi H, Oguma E, Kayama F. The effects of iron deficiency on oestradiol-induced suppression of erythropoietin induction in rats: implications of pregnancy-related aanemia. Blood. 2005;106:67–74.
- Anagnostou A, Zander A, Barone J, Fried W. Mechanism of the increased splenic erythropoiesis in mice treated with oestradiol benzoate. J Lab Clin Med. 1976;88:700–6.